Oligodendrocyte differentiation and implantation: New insights for remyelinating cell therapy

Current Opinion in Neurology

Volumn 21, Issue 5, 2008, Pages 607-614

  Sher, Falak ^a   Balasubramaniyan, Veerakumar ^a   Boddeke, Erik ^a   Copray, Sjef ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cell implantation; Differentiation; Neural stem cell; Oligodendrocyte precursor cell

Indexed keywords

GROWTH FACTOR; MEROSIN; MYELIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX8; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; EPIGENETICS; EXTRACELLULAR MATRIX; MICROGLIA; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; REMYELINIZATION; REVIEW; SOMATIC CELL;

CELL DIFFERENTIATION; CELL SURVIVAL; EPIGENESIS, GENETIC; HUMANS; MYELIN SHEATH; OLIGODENDROGLIA; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY;

EID: 53549109124     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32830f1e50     Document Type: Review

References (69)

1. Goldman SA, Lang J, Roy N, et al. Progenitor cell-based myelination as a model for cell-based therapy of the central nervous system. Ernst Schering Res Found Workshop 2006; 195-213.
2. Karussis D, Kassis I. Use of stem cells for the treatment of multiple sclerosis. Expert Rev Neurother 2007; 7:1189-1201. This study nicely summarizes the experience with the use of different types of stem cells in CNS disease models and discusses the advantages and disadvantages of each stem cell type for future clinical applications in MS.
3. Miller RH, Bai L Cellular approaches for stimulating CNS remyelination. Regen Med 2007; 2:817-829. Good review and discussion on the use of stem cells for the treatment of demyelinating diseases.
4. Westerlund U, Svensson M, Moe MC, et al. Endoscopically harvested stem cells: a putative method in future autotransplantation. Neurosurgery 2005; 57:779-784.
5. **], has significantly altered embryonic stem cell research by demonstrating that it is possible to induce the generation of human pluripotent stem cells from skin fibroblasts.
6. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872. This study from the laboratory of Yamanaka is the human fibroblast follow-up of their very first groundbreaking study on the induction of pluripotent stem cells from mouse fibroblasts
7. **), has significantly altered embryonic stem cell research by demonstrating that it is possible to induce the generation of human pluripotent stem cells from skin fibroblasts.
8. Wemig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 2008; 105:5856-5861. This elaborate study shows that IPS cells indeed can generate neural stem cells, which differentiate into neurons and functionally integrate into the Mat brain aftar implantation. With an embryonic stem-derived protocol to induce dopaminergic neuron formation, IPS cells can form dopamine-producing cells that improve symptoms in a rat model for Parkinson's disease.
9. Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogrammingofterminatly differentiated mature B lymphocytes to pluripotency. Cell 2008; 133:250-264. Although fully differentiated B-lymphocytes require additional adaptation of the IPS induction protocol with the four plunpotency genes, this study nicely demonstrates that also easily accessible somatic cells like B-lymphocytes can be transformed into pluripotent embryonic stem cell-like IPS cells.
10. Spassky N, Goujet-Zalc C, Parmantier E, et al. Multiple restricted origin of oligodendrocytes. J Neurosci 1998; 18:8331-8343.
11. Battiste J, Helms AW, Kim EJ, et al. AscII defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord. Development 2007; 134:285-293. Interesting study showing that AscH- (Mash-1) expressing progenitors in the developing spinal cord give rise first to dorsal hom intemeurons and subsequently to late-bom oligodendrocytes.
12. Cai J, Qi Y, Hu X, et al. Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron 2005; 45:41-53.
13. Vallstedt A, Klos JM, Ericson J. Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron 2005; 45:55-67.
14. Kessaris N, Fogarty M, lamarelli P, et al. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 2006; 9:173-179.
15. Kessaris N, Pringle N, Richardson WD. Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philos Trans R Soc Lond B Biol Sci 2008; 363:71-85. Comprehensive review focusing on the different extracellular signals and intracellular responses that influence glial generation and the choice between oligodendrocyte and astrocyte fates.
16. Richardson WD, Kessaris N, Pringle N. Oligodendrocyte wars. Nat Rev Neurosci 2006; 7:11-18.
17. Menn B, Garcia-Verdugo JM, Yaschine C, et al. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 2006; 26:7907-7918.
18. Nait-Oumesmar B, Picard-Riera N, Keminon C, et al. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 2007; 104:4694-4609. This is the first study on human postmortem brains from patients with MS specifically addressing the mobilization of PSA-NCAM(+) progenitors to periventricular lesions.
19. Nait-Oumesmar B, Picard-Riera N, Keminon C, Baron-VanEvercooren A. The rote of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis. J Neural Sci 2007; 265:26-31. Comprehensive review on the role of endogenous neural stem cells in myelin repair in both animal models of demyelination and MS.
20. Nicolay DJ, Doucette JR, Nazarali AJ. Transcriptional control of oligodendrogenesis. Glia 2007; 55:1287-1299. An excellent and comprehensive review of all known extrinsic and intrinsic factors involved in oligodendrogenesis. It gives a very detailed overview of the expression of the major transcription factors in oligodendrocytes at different embryonic stages.
21. Kessaris N. Jamen F, Rubin LL, Richardson WD. Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signaling pathways in neocortical precursors. Development 2004; 131:1289-1298.
22. Mekki-Dauriac S, Agius E, Kan P, Cochard P. Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 2002; 129:5117-5130.
23. Lachapelle F, vellana-Adalid V, Nait-Oumesmar B, Baron-Van EA. fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 2002; 20:390-403.
24. Hsieh J, Aimone JB, Kaspar BK, et al. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 2004; 164:111-122.
25. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. lnterleukin-1 beta promotes repair of the CNS. J Neurosci 2001; 21:7046-7052.
26. Wegner M. A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 2008; 35:3-12.
27. Xin M, Yue T, Ma Z, et al. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 2005; 25:1354-1365.
28. Hack MA, Saghatelyan A, deChevigny A, et al. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 2005; 8:865-872.
29. Cheng X, Wang Y, He Q, et al. Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 2007; 25:3204-3214. Experiments described in this study on adult spinal cord OPCs suggest that blocking BMP signalling combined with Olig1/2 overexpression could be a useful therapeutic strategy to enhance endogenous remyelination.
30. Parras CM, Hunt C, Sugimori M, et al. The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. J Neurosci 2007; 27:4233-4242. This study shows for the first time that Mashi cooperates in vivo with Olig2 in oligodendrocyte specification.
31. Gokhan S, Marin-Husstege M, Yung SY, et al. Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 2005; 25:8311-8321.
32. Marin-Husstege M, He Y, Li J, et al. Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings. Glia 2006; 54:285-296.
33. Wegner M, Stolt CC. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci 2005; 28:583-588.
34. Stolt CC, Schlierf A, Lommes P, et al. SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function. Dev Cell 2006; 11:697-709.
35. He Y, Dupree J, Wang J, et al. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 2007; 55:217-230. Good, interesting study in which the authors have identified the transcription factor YY1 as a critical regulator of oligodendrocyte progenitor differentiation.
36. Nielsen JA, Berndt JA, Hudson LD, Armstrong RC. Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells. Mol Cell Neurosci 2004; 25:111-123.
37. Balasubramaniyan V, Boddeke E, Bakels R, et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006; 143:939-951.
38. Feng J, Fouse S, Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatr Res 2007; 61:58R-63R. This review focuses on the role of DNA methylation and histone modifications in neural lineage differentiation.
39. Hsieh J, Gage FH. Epigenetic control of neural stem cell fate. Curr Opin Genet Dev 2004; 14:461-469.
40. Tang HL, Zhu JH. Epigenetics and neural stem cell commitment. Neurosci Bull 2007; 23:241-248. Another timely review focusing on new insights into the epigenetic mechanism for neural stem cell fate.
41. Shen S, Casaccia-Bonnefil P. Posttranslational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease. J Mol Neurosci 2008; 35:13-22. Excellent review on epigenetics and oligodendrogenesis.
42. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002; 22:10333-10345.
43. Liu A, Han YR, Li J, et al. The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J Neurosci 2007; 27:7339-7343. This study reports on extensive studies on NG2+ oligodendrocyte progenitors demonstrating that the ability of these cells to acquire the identity of myelinexpressing cells is dependent on the activity of HDAC.
44. Siebzehnrubl FA, Buslei R, Eyupoglu IY, et al. Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp Brain Res 2007; 176:672-678. Interesting study using novel inhibitors of histone deacetylases (iHDAC) for oligodendrogenesis research.
45. Rajasekhar VK, Begemann M. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 2007; 25:2498-2510. This well written review adequately summarizes the increasing knowledge of the role of polycomb group proteins in stem cell physiology.
46. Sparmann A, van LM. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6:846-856.
47. Dobson NR, Zhou YX, Flint NC, Armstrong RC. Musashi1 RNA-binding protein regulates oligodendrocyte lineage cell differentiation and survival. Glia 2008; 56:318-330. The very first study describing the involvement of RNA-binding proteins in oligodendrogenesis.
48. Hu JG, Fu SL, Wang YX, et al. Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway. Neuroscience 2008; 151:138-147. The authors show the dual role of PDGF-AA in oligodendrocyte precursor cell proliferation as well as their differentiation; the pathways underlying the switch from division into differentiation remain unclear.
49. Rosenberg SS, Ng BK, Chan JR. The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol 2006; 16:288-294.
50. Glaser T, Perez-Bouza A, Klein K, Brustle O. Generation of purified oligodendrocyte progenitors from embryonic stem cells. FASEB J 2005; 19:112-114.
51. Nistor Gl, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005; 49:385-396.
52. Kang SM, Cho MS, Seo H, et al. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 2007; 25:419-424. This study provides a good, simple recipe to obtain a high percentage of functional oligodendrocytes from human embryonic stem cells.
53. Izrael M, Zhang P, Kaufman R, et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 2007; 34:310-323. This study uses the strategy based on antagonizing BMP activity to obtain oligodendrocytes from human embryonic stem cells.
54. Balasubramaniyan V, Timmer N, Kust B, et al. Transient expression of Olig1 initiates the differentiation of neural stem cells into oligodendrocyte progenitor cells. Stem Cells 2004; 22:878-882.
55. Copray S, Balasubramaniyan V, Levenga J, et al. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 2006; 24:1001-1010.
56. Du ZW, Li XJ, Nguyen GD, Zhang SC. Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression. Mol Cell Neurosci 2006; 33:371-380.
57. Liu Z, Hu X, Cai J, et al. Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 2007; 302:683-693. This study reports on experiments on the development of OPC in embryonic chicken spinal cord and nicely explains the intricate interactions between Olig2 and Sox10.
58. Stankoff B, Aigrot MS, Noel F, et al. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 2002; 22:9221-9227.
59. Hu X, Hicks CW, He W, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 2006; 9:1520-1525.
60. Coman I, Barbin G, Charles P, et al. Axonal signals in central nervous system myelination, demyelination and remyelination. J Neural Sci 2005; 233:67-71.
61. Ishibashi T, Dakin KA, Stevens B, et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006; 49:823-832.
62. Williams A, Piaton G, Lubetzki C. Astrocytes - friends or foes in multiple sclerosis? Glia 2007; 55:1300-1312. Very interesting review on the still puzzling role of astrocytes in MS lesions.
63. Olsen IM, ffrench-Constant C. Dynamic regulation of integrin activation by intracellular and extracellular signals controls oligodendrocyte morphology. BMC Biol 2005; 3:25.
64. Baron W, Colognato H, ffrench-Constant C. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 2005; 49:467-479.
65. Setzu A, Lathia JD, Zhao C, et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006; 54:297-303.
66. Kotter MR, Li WW, Zhao C, Franklin RJ. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006; 26:328-332.
67. Butovsky O, Ziv Y, Schwartz A, et al. Microglia activated by IL.-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adutt stem/progenitor cells. Mol Cell Neurosci 2006; 31:149-160.
68. Butovsky O, Landa G, Kunis G, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 2006; 116:905-915.
69. Walczak P, Bulte JW. The role of noninvasive cellular imaging in developing cell-based therapies for neurodegenerative disorders. Neurodegener Dis 2007; 4:306-313. Comprehensive review and must read for all those interested in applying noninvasive cellular imaging.